Basic Permethrin Information

• INN (International Nonproprietary Name): Permethrin
• Brand Names Available In United Kingdom: Lyclear (cream 5%, lotion 1%) and other global brands include Nix, Acticin, Elimite; regional products vary by supplier.
• ATC Code: P03AC04
• Forms & Dosages: Cream 5%; Lotion 1%; Spray 0.25% and 0.5%; Combination lice kits available.
• Manufacturers In United Kingdom: Major suppliers listed include GlaxoSmithKline (Lyclear) and Reckitt (Nix), with other global manufacturers such as Taro Pharmaceuticals and Cipla supplying products to the market.
• Registration Status In United Kingdom: Permethrin is authorised across Europe for scabies and lice and is widely registered under EMA-approved indications; availability in practice is concentration dependent.
• OTC / Rx Classification: 1% formulations for head lice are generally OTC; 5% cream for scabies is commonly prescription-only in many systems.

Key Findings From Recent Trials

Major 2022–2025 Studies

Clinicians ask whether permethrin still works as well as it used to.

Recent high-quality randomised controlled trials and pooled analyses from 2022–2025 continued to support permethrin as a first-line topical agent for scabies and head lice.

Studies evaluated 5% cream for scabies and 1% lotion for pediculosis using real-world UK‑relevant dosing regimens.

Main Outcomes

When applied correctly, a single overnight application of 5% cream achieved clinical cure rates above 80–90% at 2–4 weeks in most trials.

Permethrin 1% lotion delivered rapid knockdown of lice but sometimes required a repeat application at day 7 to secure sustained cure.

Trial protocols matched practical use: 8–14 hour contact for scabies and around 10 minutes for a 1% lice application.

Safety Observations

Across trials, adverse events were mainly local skin reactions such as burning, erythema and transient pruritus.

Systemic absorption was negligible in adults and no consistent systemic safety signals emerged in the reviewed studies.

Investigators noted emerging regional reports of reduced lice susceptibility, prompting head‑to‑head comparisons with malathion and oral ivermectin.

Strengths of the evidence include multiple randomised controlled trials and pooled analyses; limitations include variability in patient adherence to application instructions and incomplete regional resistance surveillance.

Clinical Mechanism Of Action

Layman’s Explanation

Patients want a simple explanation: permethrin paralyses and kills mites and lice on contact.

The topical product sits on skin or hair shafts and acts where the parasite lives, not systemically.

Scientific Breakdown

Permethrin is a synthetic pyrethroid with ATC code P03AC04 that targets arthropod nerve membranes.

It prolongs the opening of voltage‑gated sodium channels in insect nerve cells, causing repetitive firing, paralysis and death.

At effective concentrations, permethrin also reduces egg viability when nits receive sufficient contact time.

Pharmacokinetics (Brief)

Topical absorption is minimal with standard 1–5% formulations and therapeutic concentrations remain localised to skin or hair shafts.

Cutaneous metabolism is rapid and systemic uptake is negligible in otherwise healthy adults.

Resistance Mechanisms (Brief)

Resistance in lice is associated with target‑site kdr‑type sodium channel mutations and increased detoxification via esterases and cytochrome P450 enzymes.

These mechanisms explain regional treatment failures and the need to consider alternatives when permethrin efficacy falls.

Correct application—ensuring adequate saturation and contact time—is as important as mechanism for clinical success in the UK setting.

Scope Of Approved And Off‑Label Use

United Kingdom Approvals

Permethrin 5% cream is authorised for scabies while 1% lotions and creams are authorised for head lice under EMA and national approvals.

In many countries the 5% cream is prescription‑only while 1% lice formulations are available OTC.

Manufacturers such as GlaxoSmithKline market Lyclear in UK/Europe in suitable strengths for these indications.

Notable Off‑Label Trends

Clinicians sometimes use permethrin off‑label in combination with oral ivermectin for refractory or crusted scabies under specialist advice.

Topical permethrin has an adjunctive role during institutional body‑lice outbreaks or as part of combined environmental measures, though veterinary products must not be used on people.

Emerging strategies include repeated short‑contact regimens to improve adherence in domiciliary care settings; evidence quality for these approaches is variable and specialist input is advisable.

When using off‑label combinations, document the rationale and obtain informed consent in line with UK prescribing standards.

Dosage Strategy

General Dosing

Use permethrin 5% cream for scabies and 1% lotion or cream for head lice following UK‑aligned dosing guidance.

Apply 5% cream head‑to‑toe and leave on for 8–14 hours before washing off.

For head lice, apply a 1% product to washed hair, saturate thoroughly, leave for about 10 minutes, then rinse and repeat at day 7 if live lice are still present.

Condition‑Specific Dosing

Adults and Children Aged 12 Years And Above: apply a full tube (commonly 30g or 60g) of 5% cream for scabies as a single head‑to‑toe application.

Children Aged 6–12 Years: use up to half a tube of 5% cream for scabies and adjust volume to cover body surface evenly.

Children Aged 1–5 Years: up to a quarter tube of 5% cream is typical for scabies treatment.

Infants Aged 2 Months–1 Year: up to one‑eighth of a tube of 5% cream may be used; do not use permethrin in neonates under 2 months.

Lice Regimen

Apply 1% lotion to saturate the hair and scalp, leave for approximately 10 minutes, then rinse.

Combine with wet‑combing to remove nits and repeat the application on day 7 if any live lice are detected.

Special Populations

Do not use in neonates under 2 months due to lack of established safety data.

Elderly patients usually require no dose change but assess skin fragility before application.

Treat close household contacts concurrently in scabies to reduce reinfestation risk.

Safety Protocols

Contraindications

Absolute contraindications include known hypersensitivity to permethrin, synthetic pyrethroids or any excipients in the product.

Do not use permethrin in neonates under 2 months of age because safety has not been established for that group.

Avoid or use with caution on severely inflamed or weeping skin and in patients with ragweed allergy due to possible cross‑reactivity.

Adverse Effects

Most adverse effects are local and mild, including burning, stinging, pruritus, erythema and oedema at the application site.

Occasional neurological sensations such as numbness or tingling and rare systemic complaints like headache or dizziness have been reported.

If a severe local reaction develops, stop the product and seek clinical review.

Topical emollients or short‑course mild topical corticosteroids may be used for irritant dermatitis under supervision.

Accidental ingestion requires emergency care; symptoms can include nausea, vomiting and central nervous system effects.

Record allergy status and advise correct wash‑off timing to reduce irritation risk, particularly in infants and frail older people.

Interaction Mapping

Food Interactions

Because systemic absorption is negligible with topical use, there are no clinically meaningful food–drug interactions.

Patients do not need to change diet or fasting status for topical permethrin application.

Drug Combinations To Avoid

Avoid concurrent use of multiple topical neurotoxic agents such as lindane or additional pyrethroids because of theoretical additive local toxicity and lack of benefit evidence.

When combining topical permethrin with systemic agents like oral ivermectin for severe scabies, document the rationale and monitor the patient though combined use has been reported as acceptable in refractory cases.

Special Notes

Do not apply permethrin to extensively broken or inflamed skin where systemic absorption could theoretically increase.

Do not substitute human topical formulations with veterinary sprays or dips, which have different concentrations and excipients.

Patient Experience Analysis

Survey Data

Surveys from the UK and abroad report high patient satisfaction when permethrin cures the infestation after straightforward application.

Common complaints include inconvenience of overnight full‑body application for scabies and transient local irritation.

Perceived treatment failure often reflects incorrect application, reinfestation or untreated household contacts rather than drug inefficacy.

Forum Trends

Parenting forums and support groups frequently discuss the difficulty of applying 5% cream to young children and concern about chemical exposure.

Users often combine permethrin lice treatment with systematic wet‑combing to improve outcomes and remove nits.

OTC availability of 1% lice products is valued for immediate access, while prescription requirements for 5% scabies cream can be perceived as a barrier by some families.

Clinicians can reduce negative experiences by demonstrating application technique, advising on treating close contacts and supplying clear written instructions.

Distribution And Pricing Landscape

Permethrin is sold under brands such as Lyclear in the UK and Nix in other markets, with multiple generic suppliers active globally.

Product strengths include 5% cream for scabies and 1% lotion or cream for head lice; environmental sprays exist at lower strengths for bedding and surfaces.

In the UK, access routes typically involve an NHS prescription for 5% scabies cream and community pharmacy OTC supply for 1% lice products.

OTC 1% lice kits are generally low cost and widely stocked in pharmacies and supermarkets.

Price for a prescription 5% tube can vary depending on NHS tariff or private purchase arrangements, and supply chain variability can affect local pricing.

Permethrin remains a cost‑effective topical option compared with systemic treatments such as oral ivermectin.

In our online pharmacy, permethrin is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Alternative Options

Comparison Table

• Malathion: alternative for suspected permethrin‑resistant lice with strong ovicidal activity.
• Benzyl Benzoate: inexpensive scabicide that can be more irritating to the skin.
• Crotamiton: additional topical option for scabies with variable efficacy.
• Oral Ivermectin: effective for crusted or refractory scabies and difficult lice but is systemic and requires prescribing considerations.

Pros And Cons

Permethrin Pros: proven efficacy for scabies and lice, low systemic absorption and OTC lice options for convenience.

Permethrin Cons: local irritation in some patients and emerging regional lice resistance that may reduce effectiveness.

Malathion Pros: generally effective against permethrin‑resistant lice and has ovicidal effects.

Malathion Cons: odour and flammability concerns and prescription status varies.

Ivermectin Pros: useful systemic option for extensive or refractory infestations and for institutional outbreaks when topical measures fail.

Ivermectin Cons: systemic exposure, contraindications in some populations and prescriber familiarity required.

Choice should reflect efficacy data, safety, local resistance patterns and patient preference in UK practice.

Regulatory Status

Global Approvals Overview

Permethrin is approved worldwide for topical treatment of scabies and lice by agencies including the FDA and EMA.

Many national regulators list permethrin products for ectoparasitic indications and maintain pharmacovigilance records focused on local skin reactions.

UK‑Specific Notes

EMA‑authorised formulations include 5% cream and 1% lotion, and many UK prescribers follow these licensed indications and age limits.

Consult the relevant summary of product characteristics and national formularies for current licence details and age restrictions.

For OTC sales of 1% lice products, pharmacists should provide counselling on correct application and advise GP review for treatment failure or severe dermatitis.

Report adverse reactions as required via the MHRA Yellow Card scheme where appropriate.

Consolidated FAQ

Rapid Answers For Clinicians & Patients

Is Permethrin Safe For Children?

Yes for children according to licensed age ranges; do not use in neonates under 2 months and follow tube fraction guidance for younger children.

How Long To Leave 5% Cream On For Scabies?

Leave 5% cream on for 8–14 hours applied head‑to‑toe and repeat in 7 days if live mites persist or as directed by a clinician.

Can I Use Permethrin For Environmental Spraying?

Only use approved surface formulations for bedding or clothing; do not use human topical products as room sprays.

What If Treatment Fails?

Check application technique, ensure close contacts were treated and consider resistance or alternative agents such as malathion or oral ivermectin if appropriate.

OTC Access In UK?

1% lice products are commonly available OTC while 5% scabies cream often requires a prescription in many settings.

Visual Guide

Infographic Content Outline

Design an infographic showing stepwise application for scabies, with a head‑to‑toe map and timing guidance.

Create a separate lice treatment workflow: wash, apply, comb, repeat at day 7 and include a small combing demonstration panel.

Include an age‑based dosing chart with tube fraction illustrations and icons for common side effects such as burning or rash.

Patient Leaflets & Icons

Produce a two‑sided leaflet: clinician summary with dosing and follow‑up times and a simplified patient version with pictograms.

Use NHS colour cues, show examples of Lyclear packaging for UK recognition and include a clear warning that veterinary products are not for human use.

Storage And Transport

Recommended Conditions

Store permethrin topical products at 20–25°C and protect them from light and moisture.

Do not freeze permethrin formulations and keep tubes out of reach of children.

Handling For Clinics & Pharmacies

Use temperature‑controlled parcels for transport where possible and avoid exposing stock to direct sunlight or high humidity in the dispensary.

Maintain an activity log for lot numbers and expiry dates during mass distribution and follow local hazardous pharmaceutical waste rules for disposal of unused or expired tubes.

Monitor MHRA or NHS alerts for batch recalls and rotate stock to avoid expiry during outbreak periods.

Guidelines For Proper Use

Stepwise Clinician Checklist

Confirm the indication and distinguish scabies from other pruritic conditions before prescribing.

Check allergies, age limits and choose the appropriate formulation: 5% cream for scabies, 1% for lice.

Demonstrate application technique, advise treatment of household contacts for scabies and document batch and prescribing details.

Arrange follow‑up at 1–2 weeks and escalate to alternatives if there is treatment failure or severe reaction.

Patient Counselling Script

Explain the purpose of the medication and show how much to apply using the tube fraction chart for children.

Tell the patient how long to leave the product on: 8–14 hours for 5% cream and about 10 minutes for 1% lotion.

Advise on repeat policy: day 7 for lice if live lice are seen, and treating all close contacts for scabies.

Emphasise not to use veterinary products and to store at room temperature away from heat and sunlight.

Delivery Across United Kingdom